Adiponectin Test – Metabolic Health & Inflammation Marker
Adiponectin is a hormone produced by adipose tissue that plays a protective role in metabolic and cardiovascular health. Low adiponectin levels are associated with metabolic dysfunction, insulin resistance, obesity, and increased cardiovascular disease risk. Adiponectin is unique among adipokines in being inversely correlated with metabolic syndrome severity.
What is Adiponectin and Why It Matters
Adiponectin is an adipokine that enhances insulin sensitivity, promotes fatty acid oxidation, and reduces inflammation. Higher adiponectin levels are protective against metabolic disease. Unlike other adipokines, adiponectin decreases with obesity and metabolic dysfunction.
Low Adiponectin and Metabolic Dysfunction
Low adiponectin (<4 μg/mL) is associated with insulin resistance, type 2 diabetes, metabolic syndrome, and fatty liver disease. Adiponectin deficiency impairs glucose metabolism and promotes ectopic fat deposition in organs.
Adiponectin Normal Ranges
Normal adiponectin levels are typically >9 μg/mL, with higher levels conferring greater metabolic protection. Levels between 4-9 μg/mL indicate intermediate risk, while levels below 4 μg/mL indicate elevated metabolic disease risk.
Adiponectin and Cardiovascular Health
Low adiponectin is an independent cardiovascular risk factor. Adiponectin has cardioprotective and anti-atherosclerotic properties, reducing inflammation, improving endothelial function, and decreasing thrombotic risk.
Increasing Adiponectin Levels
Adiponectin increases with weight loss, regular exercise, and anti-inflammatory diet. Omega-3 fatty acids, polyphenols, and thiazolidinedione medications can increase adiponectin. Improving insulin sensitivity through lifestyle modifications is the primary strategy for raising adiponectin.
How to interpret your results
An adiponectin result is a snapshot of how well your adipose tissue is performing as an endocrine organ — not just how much fat you carry. Labs report the result in micrograms per milliliter (µg/mL), and the number on your report only makes sense when read against the reference range your laboratory prints alongside it. Slight differences between assays mean a value at the boundary of “normal” may shift if the same sample were run elsewhere, so the printed range is the right anchor.
Two pieces of context shift how your number reads:
| Factor | What it changes |
|---|---|
| Sex | Cleveland Clinic publishes separate ranges for males and females |
| Body mass index | Higher BMI is associated with lower circulating adiponectin |
| Body composition extremes | Severe underweight (anorexia nervosa, malnutrition) can drive levels unusually high |
| Diabetes medication | Metformin and thiazolidinediones raise adiponectin |
What a low result usually points to
Low adiponectin most often travels with the conditions the hormone normally helps prevent. Reduced levels are seen in insulin resistance, prediabetes, type 2 diabetes, gestational diabetes, atherosclerosis, and obesity. Because circulating adiponectin declines as BMI rises, a low number in someone with excess body fat is expected; a low number in a lean person is more striking and may suggest a genetic contribution to insulin resistance.
What a high result can mean
Higher adiponectin within the normal range is generally favorable for metabolic and cardiovascular protection. Unusually high levels, however, are not always a good sign — they appear in people with severe underweight, including those with anorexia nervosa or malnutrition. In other words, the relationship between adiponectin and health is U-shaped at the extremes, and context matters.
How to prepare for an adiponectin test
Adiponectin is measured from a standard blood draw, so preparation is broadly similar to other metabolic blood tests. Cleveland Clinic does not publish specific fasting or timing requirements for the adiponectin assay itself. Because the test is often ordered alongside markers that do require fasting (such as fasting glucose and a lipid profile), your healthcare provider may ask you to fast for 8–12 hours to keep all results comparable.
A few practical points worth checking with your ordering clinician before the appointment:
- Whether you should fast, and for how long, given the other tests on the same requisition
- Whether to take or hold your usual medications that morning, particularly diabetes medications like metformin or thiazolidinediones, which are known to raise adiponectin
- Whether recent significant weight changes, acute illness, or a course of new medication should be flagged on the form
- Whether the lab uses a specific reference range you should ask for in writing, because numerical cut-offs vary slightly by assay
Adiponectin is not part of routine cardiometabolic screening in most US primary-care offices, so an order usually has to be requested specifically. If your clinician is running adiponectin as part of a broader workup, expect related markers on the same draw — commonly fasting glucose, HbA1c, insulin, a lipid profile, and an inflammation marker such as hs-CRP.
Who should consider testing adiponectin
Adiponectin is a research-leaning marker rather than a screening test, so most healthy adults do not need it. Cleveland Clinic notes that providers may recommend an adiponectin blood test to help diagnose conditions such as type 2 diabetes and metabolic syndrome, while also pointing out that other, more common tests are usually used first for these same conditions. That positioning matters: adiponectin adds nuance to a workup, but it rarely changes a diagnosis on its own.
Situations where the test can add value
The marker is most informative when standard panels leave a question unanswered or when adipose-tissue dysfunction is specifically on the differential:
- A lean person with documented insulin resistance, where a genetic contribution may be at play
- A patient with metabolic syndrome features whose risk profile is hard to read from BMI and lipids alone
- A patient with congenital or HIV-related lipodystrophy, where adiponectin is typically low and reflects abnormal fat distribution
- A research or specialist setting tracking response to interventions known to raise adiponectin, such as weight loss, exercise, or diabetes medication
If none of these fit your situation, a standard cardiometabolic panel is usually a more efficient first step. Talk to your clinician about whether adiponectin would actually change the management plan before adding it to a draw.
Adiponectin and obesity: the inverse relationship
Most hormones produced by fat cells rise as fat mass grows. Adiponectin does the opposite. Circulating levels consistently decline with increasing body mass index, a pattern documented across more than two decades of research and thousands of publications. People with obesity therefore tend to have lower adiponectin than lean peers, and weight loss in people with obesity raises adiponectin back toward higher values.
Why the inverse pattern matters
The inverse relationship is what makes adiponectin biologically interesting. Cleveland Clinic puts the rule simply: “the more body fat someone has, the lower their adiponectin levels are, and vice versa”. Researchers have used this pattern as a mechanistic link between obesity and the increased incidence of cardiovascular disease in obese individuals. The marker reflects the metabolic state of fat tissue, not only its quantity, which is why it can flag adipose-tissue dysfunction in people whose other numbers look unremarkable.
The other end of the curve
The inverse pattern holds at the low end of body weight too. People with severe underweight — for example from anorexia nervosa or malnutrition — show high adiponectin levels. That is not a sign of metabolic robustness; it reflects very low adipose mass. The takeaway is that “higher is better” applies within a normal-weight, normally-fed adult population, not at the extremes of body composition. Interpreting adiponectin without knowing the patient’s body composition, weight history, and nutritional status is unreliable.
Adiponectin and related metabolic markers
Adiponectin rarely travels alone. Scientists have identified several hormones that help regulate its production and release, and clinicians typically read adiponectin alongside other markers that map the same cardiometabolic territory.
Hormones that regulate adiponectin
Cleveland Clinic identifies multiple endocrine signals that influence adiponectin levels:
- Insulin appears to play a role in adiponectin production, though Cleveland Clinic notes scientists do not agree on exactly how
- Insulin-like growth factor 1 (IGF-1) and growth hormone (GH) regulate adiponectin release from adipose tissue
- Leptin, another adipokine, may also play a role in adiponectin regulation
The leptin–adiponectin relationship is the reason some specialty labs offer a paired leptin-and-adiponectin order. Leptin generally rises with fat mass while adiponectin falls, so reading the two together can sketch a fuller picture of adipose endocrine function than either marker alone.
Markers commonly ordered with adiponectin
In cardiometabolic workups, adiponectin pairs naturally with markers of glucose handling, lipid balance, and vascular inflammation. Useful companions include fasting glucose, HbA1c, insulin, a lipid profile, and hs-CRP for low-grade inflammation. None of these duplicates adiponectin’s information; using them together gives a more complete read on insulin sensitivity, dyslipidemia, and vascular risk than any single marker.
Where adiponectin acts in the body
At the tissue level, adiponectin works through two identified receptors, AdipoR1 and AdipoR2, with a third binding protein called T-cadherin contributing to its localization on vascular and muscle tissue. This receptor biology is one reason serum adiponectin alone may not capture the full story of how the hormone is acting locally. The clinical implication for now is modest: research continues, and most labs still report a single circulating adiponectin number rather than tissue-level activity.
Frequently asked questions
How is the adiponectin test performed?
Adiponectin is measured from a routine venous blood draw. A clinician collects a small blood sample, the lab measures circulating adiponectin in micrograms per milliliter, and your provider compares the result to a sex- and BMI-specific reference range printed on your lab report.
How much does an adiponectin test cost?
Cost depends on the lab, the assay, and your insurance, and Cleveland Clinic does not publish a specific price. Because adiponectin is not part of routine screening, many insurance plans will not cover it without a clinical justification. Ask the ordering lab for a self-pay estimate before the draw.
Can my doctor order an adiponectin test?
Yes. Cleveland Clinic notes that healthcare providers may recommend an adiponectin blood test, particularly when investigating conditions like type 2 diabetes or metabolic syndrome. Availability still varies by region and lab, so your provider may need to send the sample to a specialty reference lab.
Is the adiponectin test commonly ordered?
No — it remains a specialized rather than routine test. Cleveland Clinic explicitly notes that other, more common tests are typically used first to diagnose conditions like type 2 diabetes and metabolic syndrome, with adiponectin reserved for situations where it adds clinical value.
What does a high adiponectin level mean?
Higher levels within the normal range generally suggest good metabolic and cardiovascular protection. However, unusually high adiponectin can appear in people with severe underweight, including those with anorexia nervosa or malnutrition, where it reflects very low adipose mass rather than robust metabolic health.
What is the leptin-to-adiponectin ratio?
Leptin and adiponectin are both adipokines, but they move in opposite directions: leptin rises with fat mass while adiponectin falls. Some labs offer a paired order so clinicians can read both signals together; Cleveland Clinic notes leptin may help regulate adiponectin.
Do adiponectin levels differ by sex and BMI?
Yes. Cleveland Clinic publishes separate reference ranges for males and females, each further split by BMI category, because both sex and body composition shift the typical range. Always compare your result to the range that matches your group on the lab report.
Is there a genetic component to low adiponectin?
Possibly. Cleveland Clinic notes that people who have insulin resistance without obesity usually have low adiponectin as well, suggesting a genetic factor in how adiponectin is produced and regulated independently of body weight.
When to talk to your doctor
Adiponectin is rarely a stand-alone reason to seek care, but the conditions linked to it often are. Consider scheduling a clinical visit if any of the following apply, and bring your full lab report so your clinician can read adiponectin alongside the rest of your panel:
- Your adiponectin result falls outside the reference range for your sex and BMI category on the lab report, in either direction
- You have a low adiponectin value together with documented insulin resistance, prediabetes, type 2 diabetes, or gestational diabetes
- You are lean but have signs of insulin resistance alongside low adiponectin, since a genetic contribution may be involved
- You have atherosclerosis or known cardiovascular disease and your adiponectin is low — adiponectin has anti-inflammatory effects that help protect your heart and blood vessels, so low values may add context to your risk picture
- You are unusually underweight or have a diagnosis of anorexia nervosa or malnutrition and your adiponectin is high — the finding reflects very low fat mass and warrants nutritional review
- You have congenital or HIV-related lipodystrophy, which is associated with low adiponectin
- You are considering meaningful changes to your eating patterns or exercise routine in response to your result — Cleveland Clinic specifically advises talking to a healthcare provider before making drastic changes
Diabetes medications such as metformin and thiazolidinediones are known to raise adiponectin, but they are prescribed to treat diabetes rather than to raise this marker — any medication decisions should be made with your prescribing clinician.
References